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Abstract
The management of aggressive behaviour has always 
been a criticai issue in psychiatry. Finding measures that 
can be used to accurately predict the likelihood of 
assaultative behaviour and thus ensure timeous appro­
priate pharmacological management remains a dilemma. 
The study objective was to investigate the naturalistic, 
pharmacological management of inpatient aggressive 
behaviour in a group of 50 schizophrenic subjects with a 
view to determine: (1) whether a presenting history of 
recent violence lead to altered pharmacological manage­
ment and (2) whether the NOSIE could be regarded as a 
useful assessment tool with regards to inpatient behav­
iour management. No significant difference could be 
demonstrated between the 2 subsets of subjects (his­
tory of violence vs none) with respect to total doses of 
medication administered. No statistical correlation could 
be found between the total NOSIE score and the dose of 
psychotropic medication used. The relationship between 
a subset of NOSIE-items and the total dose of medica­
tion was more complex and a clear linear relationship 
could be demonstrated for a total score of 0 to 5. In this 
particular ward setting a presenting history of recent 
violent behaviour did not influence the administration 
of medication and neither could the clinical judgement 
employed by the nursing staff to manage inpatient be­
haviour be captured by the NOSIE. However, a five-item 
subset of the NOSIE with questions relating to aggres­
sion and irritability warrants further scrutiny in this re­
gard.
Abstrak
Die hantering van aggressiewe gedrag is een van die 
kritiese vraagstukke in psigiatrie. Dit bly ‘n dilemma om 
assesseringskale te vind waarmee die waarskynlikheid 
van die voorkoms van aggressie akkuraat voorspel kan 
word en die resultate derhalwe aangewend kan word vir 
toepaslike farmakologiese ingrepe. Die doel van hierdie 
studie was om die n a tu ra lis tiese  farm akologiese 
hantering van binnepasiënt aggressiewe gedrag in ‘n 
groep van 50 skisofrenie pasiente te bestudeer met die 
oog daarop om te bepaal: (1) o f ‘n presenterende 
geskiedenis van onlangse aggressie lei tot veranderde 
farmakologiese hantering en (2) of die NOSIE as ‘n 
bru ikbare  assesserin g sk aa l benut kan w ord met 
betrekking tot binnepasient gedragshantering. Geen 
beduidende verskil kon gedemonstreer word tussen die 
twee groepe (geskiedenis van aggressie vs geen) met 
verwysing na die totale dosis medikasie toegedien nie. 
Geen statistiese korrelasie kon gevind word tussen die 
totale NOSIE-telling en die dosis psigotrope medikasie 
toegedien nie. Die verhouding tussen ‘n subgroep van 
NOSIE-items en die totale dosis medikasie toegedien 
was meer kompleks en ‘n duidelike liniêere verhouding 
kon gedemonstreeer word vir ‘n totale telling van 0 tot 
5. Binne hierdie spesifieke saalomgewing word die 
toedien ing  van m edikasie nie beïnv loed  deur ‘n 
presenterende geskiedenis van onlangse aggressiewe 
gedrag nie. So ook kon die verpleegstaf se kliniese 
o o rd ee l m et b e trek k in g  to t d ie  h an te rin g  van 
binnepasient gedrag nie deur die NOSIE vasgevang 
w ord nie. ‘n Vyf-item  N O SIE -subgroepvrae wat 
betrekking het op aggressie en irritasie benodig egter 
spesifiek verdere ondersoek in hierdie opsig.
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Background
Despite the fact that aggressive behaviour occurs only in a 
small minority of schizophrenia patients, the image of the 
violent schizophrenic patient is a common misperception 
in the public’s mind (Ehmann et al, 2001:716; Volavka, 
1999:43). Furthermore, the media also propagates the as­
sumed conventional and very destructive stereotype of a 
clear and definite association between violence and mental 
disorder. As illustrated by Johnston (Johnston and Taylor, 
2003:819), media representation of violent acts committed 
by people with mental disorders tends to be that o f images 
of random, serious violent acts against strangers whereas 
studies of general psychiatric patients do not support this 
representation. In actual fact few cases of serious or homi­
cidal violence have been reported and such acts are also 
more likely to be against intimates than strangers.
Although it is important to address these public miscon­
ceptions, the truth is that mental health workers, due to 
their therapeutic relationship with patients, are in fact very 
familiar with the consequences of violent behaviour when 
it does occur (Hector, 1998:466). Ehmann et al (2001:7 16), 
reported that the incidence of assaultative behaviour by 
psychiatric inpatients on mental health workers in the United 
States reached 23%, compared to the 1-year prevalence of 
2% in the general population..In a study by Currier (2000:21), 
done at psychiatric emergency services in the United States, 
high rates of violence by patients towards staff were found: 
the mean number of assaults per year at each site was 8,0 
(SD + /-17,5), of which 56,5% resulted in lost time from work. 
There was a 6 :1 odds ratio of nurses being assaulted rela­
tive to doctors, most likely related to nurses’ role in re­
straint application.
These incidents increase morbidity in hospitalized patients, 
interfere with clinical recovery (Pabis and Stanislav, 
1996:278) and cause serious bodily harm to patients and 
staff. Furthermore, it may necessitate restrictive interven­
tions such as seclusion and restraint, which significantly 
affect morale among patients and staff (Chengappa et al, 
2000:827). Violence also impacts directly on treatment costs 
due to, amongst others, days lost due to disability amongst 
staff members, possible legal action and compensation as 
well as high-intensity management, e.g. 1:1 nursing and X- 
rays.
Aggression occurs in several psychiatric disorders, includ­
ing agitated depression, mania, panic disorder, general anxi­
ety disorder, dementia, delirium, substance induced agita­
tion, acute psychosis and even akathisia. It is also known 
that the greater the number of psychiatric diagnoses, the 
higher the risk of violence (Volavka, 1999:43). Furthermore, 
schizophrenia patients frequently show higher rates of as­
sault than other diagnostic categories (Ehm ann et al, 
2001:716).
Four clinical characteristics contribute overwhelmingly to 
the risk of violence among persons with mental illness: (a) 
acute, poorly controlled illness; (b) non-compliance with 
medication; (c) substance abuse, particularly alcohol; and
(d) past history of violent behaviour (Buckley, 1999:52; 
Hector, 1998:466; Soyka, 2000:345; Swartz et al, 1998:75). 
With specific reference to psychotic disturbances, symp­
toms such as persecutory delusions and control and com ­
mand hallucinations have also been found to be related to 
aggression.
Preventative measures or rapidly effective treatment is thus 
essential to avoid the potential risk of violence or self-harm. 
However very little has changed in the treatment of aggres­
sive patients since the beginning o f the !970’s (Allen, 
2000:3) and currently there is no agent approved or licensed 
for the management of aggressive behaviour. This issue is 
further compounded in that psychiatric hospitals often do 
not have clear protocols with regards to the management 
of violent behaviour. Currier (2000:21) found that only 6% 
of psychiatric emergency services in the United States had 
precise, written protocols guiding the medication type, 
dosage and route of administration during acute incidents 
o f aggression.
Considering how violent behaviour influences the acute 
management of mental illness, it is surprising that this area 
has received so little attention and that it has not been the 
target of more clinical trials. One reason may be that, as 
reported by Buckley (1999:52), pharmacological studies on 
aggressive patients are extremely difficult to conduct. Ob­
stacles include ethical concerns, the validity of informed 
consent and lack of appropriate research settings. Accord­
ingly, much of the reported literature is based on augmen­
tation trials, most often as case series rather than rigor­
ously conducted clinical trials.
In the clinical setting a variety of psychotropics of differ­
ent classes have been tried for the management of acute 
aggression (Buckley, 1999:52), but there seems to be con­
tradicting views with regards to the use of the different 
agents. Prior to the development of the second-generation 
antipsychotics, high-potency conventional antipsychotics 
(prototype: haloperidol) had been the treatment of choice 
for the stabilization of acute psychosis among hospitalized 
schizophrenic patients (Feifel, 2000:27). Benzodiazepines 
have also achieved popularity because of their safety and 
tolerability and according to a study by Allen (2000:11), all 
available evidence suggests that benzodiazepines are at 
least as effective as haloperidol alone.
Furthermore, despite the perceived advantages of the newer, 
second-generation antipsychotics, a study by Ereshefsky 
(1999:20) reported that rapid calming is not always evident 
in many patients with orally administered second genera­
tion medication and that, during the crisis management 
phase for patients with psychotic disorders, a continuing 
need for intram uscular therapy using benzodiazepines, 
neuroleptics or combinations of both still exists.
Therefore, although current research advocates the use of 
benzodiazepines and second generation antipsychotics 
rather than conventional neuroleptics (Allen, 2000:3) in the 
acute setting, benzodiazepines and typical antipsychotics 
are often still clinically regarded as the first choice for man­
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ag ing  acu te  ag g re ss io n , w ith  se c o n d -g en e ra tio n  
antipsychotics more often utilized for persistent aggres­
sion (Allen, 2000:11; Currier, 2000:21).
To date, empirical studies are also limited by lack of uni­
formity in defining aggression and violence. Some studies 
have referred to violence as both verbal and physical ag­
gression, others as only physical aggression, and still oth­
ers as physical aggression that resulted in significant in­
jury (Hughes and Kleespies, 2003:10).
Therefore, considering the practical implications, it should 
also be clear that differing definitions of what constitutes 
violent behaviour must surely also lead to differing views 
from clinical staff as to which behaviours need to be ad­
dressed with medication and also at what time this inter­
vention is most appropriate. Thus finding measures that 
can be used to accurately  predict the likelihood of 
assaultative behaviour and thus ensure timeous appropri­
ate pharmacological management remains a priority.
The Nurse’s Observation Scale for Inpatient Evaluation 
(NOSIE), a psychiatric ward behaviour scale, originated in 
the United States and was introduced by Honigfeld 37 years 
ago. This scale is a rating scale designed to assess clinical 
changes in long-stay sch izophrenic patients (Philip, 
1977:467). In its current form the NOSIE comprises 30 items 
grouped into six scales: social competence, social interest, 
personal neatness, irritability, manifest psychosis and re­
tardation. Few studies investigating the use of the NOSIE 
are available. Some studies suggest that the NOSIE is a 
valid and reliable scale, (Honigfeld et al, 1966:180; Philip, 
1977:46729) especially in chronic care patients (Pattison 
and Rhodes, 1974:200), while a study by Hafkenscheid 
found th a t the sca le  had lim ited  p re d ic tiv e  value 
(Hafkenscheid, 1991:46).
We could find only one study that evaluated the use of the 
NOSIE to predict assaults among acute psychiatric patients 
(Swett and Mills, 1997:1177). This study evaluated the 
NOSIE, the Brief Psychiatric Rating Scale (BPRS), and the 
Mini Mental State Examination (MMSE) as predictors of 
assault that occurred during psychiatric evaluation. Patients 
who committed assaults during hospitalization and those 
who did not were compared. A high score on the irritability 
factor of the NOSIE and failure to complete the MMSE 
correctly predicted the occurrence of assault in 81 % of cases.
In this naturalistic study of schizophrenia inpatients, sub­
jects’ immediate pharmacological management in the first 
four days following an admission for an acute exacerbation 
of illness was documented. Nursing staff were also asked 
to complete two scales (NOSIE and the Overt Aggression 
Scale (OAS) (Yudovsky et al, 1986:35)) with regards to in­
patient behaviour during the first four days of admission. It 
was hypothesized that the nursing staff’s observations as 
expressed by the total NOSIE score at day 4 would not 
correlate with increased benzodiazepine and/or antipsy­
chotic use in acutely relapsed schizophrenia inpatients. As 
a secondary hypothesis it was also postulated that a his­
tory of previous violent behaviour would not lead to a dif­
ference in the immediate pharmacological management of 
these patients.
M ethodology
Fifty consecutively admitted subjects with a DSM-IV diag­
nosis of schizophrenia, with at least one prior admission to 
a psychiatric hospital, were recruited within 24-hours of 
their admission to the twenty four-bed acute male tertiary 
care unit at Stikland State Psychiatric Hospital in Bellville, 
Western Cape. This hospital serves a large population of 
urban and rural patients.
The study had a naturalistic, retrospective design and the 
treating physician and nursing staff did not have access to 
the study assessments. No prescriptive guidelines for treat­
ment were provided. Medication records were investigated 
retrospectively.
To clinically assess their current behaviour, all subjects 
were interviewed within 24 hours of admission, before any 
medication was administered. On day 4 after admission, the 
nursing staff completed a NOSIE (see Table 1) on each 
patient with regards to inpatient behaviour in the preced­
ing four days. The OAS was also completed by nursing 
staff on day 4 in order to assess whether discreet episodes 
of violence had occurred during the admission.
The Diagnostic Interview for Genetic Studies (DIGS) 
(Nurnberger et al, 1994:849) was conducted on day eight 
after admission to allow for some improvement of the acute 
psychosis and thus optimize the quality of biographic in­
formation obtained from the patient. Further collateral with 
regards to previous behaviour was obtained from previous 
case notes, the hospital file and family members* where 
possible.
The subjects were divided into a violent and non-violent 
subset according to the presence or absence of any previ­
ously documented/reported or currently exhibited violent 
behaviour as defined by Koen et al (2004:254). This defini­
tion included at least one of the following -  a lifetime his­
tory of physical violence against self, others or objects as 
reported by the patient or family or previously recorded in 
clinical notes, or significant verbal threats as reported by 
family or observed during interviews conducted on the day 
of admission.
All medication given to each patient during the first four 
days of admission was recorded retrospectively. The medi­
cation was divided into three groups: benzodiazepines, 
antipsychotics and other medication. All benzodiazepines 
were converted to the equivalent dose of lorazepam and 
antipsychotics to the equivalent dose of chlorpromazine, 
to enable cross comparison of drugs.
Prim ary statistical analysis
1. The total score o f the NOSIE.
2. The total score on a five-item subset o f the NOSIE 
(see Table 1; Items 2, 10, 12, 18,29) This subset of
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T A B L E  1 :  Nurse’ s Observation Scale for Inpatient Evaluatio n (N O S IE )
NOSIK
Instructions: For each of the 30 items you are to rate this patient’s behaviour. 
Read each statement and score according to the following key: 
Never = 0; Sometimes = I; Often = 2; Usually = 3; Always = 4
l. Is sloppy 16. Is messy in his eating habits
2. Is impatient 17. Keeps himself clean
3. Cries 18. Gets angry or annoyed easily
4. Shows interest in activities around him 19. Has to be told to follow the hospital’s routine
5. Sits, unless directed into activities 20. Giggles or smiles to himself without any apparent 
reason
6. Says he feels blue or depressed 21. Has to be reminded what to wear
7. Hears things that are not there 22. Sleeps, unless directed into activity
8. Keeps his clothes neat 23. Says he is not good
9. Tries to be friendly with others 24. Talks about his interests
10. Becomes easily upset if something doesn’t suit 
him
25. Has difficulty completing even simple tasks on 
his own
11. Refuses to do the ordinary things expected of 
him
26. Talks, mutters, or mumbles to himself
12. Is irritable and grouchy 27. Is slow moving and sluggish
13. Has trouble remembering 28. Sees things that are not there
14. Refuses to speak 29. Quick to fly off the handle
15. Laughs or smiles at funny comments or events 30. Starts up conversation with others
questions represented all items of the NOSIE that 
reflect observations with regard to irritability and 
aggression.
3. Total dose of benzodiazepines (lorazepam equiva­
lents) and the total dose of antipsychotics (chlo- 
rpromazine equivalents) were calculated.
4. Scatterplots (with lowest smoothing) were used to 
show the relationship between total antipsychotic 
and benzodiazepine dose (sum of all doses from 
baseline to Day 4) and the total score on the NOSIE.
5. Scatterplots were then repeated for the total five 
item score.
Secondary statistical analysis
1. Demographic variables were described in terms of 
descriptive statistical measures (frequencies, means, 
standard deviation, range) specific to each variable.
2. A descriptive analysis was done of all subjects that 
scored positive on the OAS.
3. T-tests (independent samples) were performed to 
investigate possible relationships between the an­
tipsychotic and benzodiazepine use and a positive 
score on the OAS.
4. T-tests (independent samples) were performed to 
investigate possible relationships between the an­
tipsychotic and benzodiazepine use and a positive 
history of violence as defined by Koen et al 
(2004:254).
Prior to the administration of any study procedures, writ­
ten informed consent was obtained from all participants 
and from their legal guardian/caretaker if any doubt existed 
as to the ability of the patient to offer consent. The study 
was approved by and conducted according to the strin­
gent ethical norms laid down by the ethics committee of the 
University of Stellenbosch. In accordance with this patients 
were clearly informed that they were allowed to withdraw 
consent at any stage, that their participation would remain 
confidential and that non-participation in the study would 
not affect their current or future treatment in any way.
Results
O f the group of 50 subjects 25 were allocated to the violent 
group and 25 to the non-violent group in accordance with 
the definitions previously described. Seven subjects had 
an incident o f inpatient aggressive behaviour recorded on
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T A B L E  2 : Clinical and socio-dem ographic variables in the violent and non-violent subgroups
Violent G roup
%
Non-violent G roup
%
Significance
X2>P
Employment status at diagnosis (unskilled) 60 77 2.21,0.14
Employment status at present (unemployed) 75 77 0.03,0.87
Marital status (married) 35 27 0.56,0.46
Alcohol abuse 53 13 6.27, 0.012
Cannabis use 33 27 0.28,0.597
Paranoid delusions 63 63 0.01,0.94
Grandiose delusions 43 43 0.005,0.944
Delusions of control 73 47 4.84, 0.028
Auditory hallucinations 73 70 0.05,0.82
Visual hallucinations 8 20 2.38,0.12
the OAS, constituting nearly 15% of the study population. 
All 7 of these subjects had been allocated to the violent 
group on admission.
The total group consisted of 38 Coloured subjects, 5 Cau­
casian and 7 of African descent. A comparison o f basic 
demographic and clinical factors including current marital 
status, level of education, number of admissions, history 
of medication compliance, substance abuse and presence 
of perceptual disturbances or delusions revealed no sig­
nificant differences between the violent and non-violent 
subsets except with regards to lifetime history of alcohol 
abuse and presence of delusions of control which were 
both significantly higher in the violent group_(See table 2).
Medication given to the violent ver­
sus non-violent subgroup during the 
first 4 days did not differ significantly 
w ith  re sp ec t to e ith e r  to ta l 
benzodiazepines (p=().l()5) or total 
antipsychotics (p=0.767). Also, when 
com paring the subgroup o f seven 
subjects who had a violent incident 
on the ward to the rest of the group, 
no difference could be demonstrated 
for either antipsychotics (p=0.174) or 
oral benzodiazepines (p=0.777). How­
ever, this group did receive signifi­
cantly more intramuscular lorazepam 
(as well as total benzodiazepines)
(p= 0.006). The mean am ount of 
benzodiasepines in the OAS-group 
was 18mg/4 days, while the rest of 
the group received a mean of only 
6,55mg/4 days.
NOSIE score and the total dose of either antipsychotics 
(expressed as chlorpromazine equivalents) (p=0.778) or 
benzodiazepines (expressed as lorazepam equivalents) 
(p=(). 131). However, the relationship between the total score 
o f the five subset item s and the total dose of either 
antipsychotics or benzodiazepines is more complex. Al­
though there seems to be no linear relationship (fig 1), it is 
worth noting that a clear linear relationship exists for a total 
score of 0 to 5, and only if the score is higher than 5 does 
this relationship disappear. This is most likely due to the 
small number of individuals scoring higher than a total of 5 
on these items. In fact, considering a five-item score of less 
or equal to 5, a significant correlation is indicated (n=45, 
r=0.547, p=().()()() 1) for the benzodiazepine use. For the
Benzodiasepine Total vs Five Item Subset Total
Fig 1
No significant relationship could be 
dem o n stra ted  betw een  the to tal
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antipsychotics (fig 2), this decrease might be more real.
In terms of the aggressive incidents reported on the OAS; 
in 6 of the 7 cases the aggressive incident resulted in the 
patient being placed in seclusion, with the seventh case 
being managed only with a verbal intervention by two mem­
bers of the nursing staff. The other 6 cases all resulted in 
members of staff having to physically restrain the subjects 
prior to seclusion. In two cases the combination of verbal 
intervention, physical restraint and seclusion proved to be 
an adequate intervention but in the other 4 cases sedation 
was needed. All subjects were sedated with lorazepam with 
doses ranging from 2-4mg. In all cases ward management 
protocol was followed and none of the incidences led to 
serious injury to the patient or staff members.
Comparing the group of 7 subjects to the total study popu­
lation (n=50) in terms of selected clinical and demographic 
data yielded the following: Only 2 of the subjects had been 
compliant with antipsychotic medication prior to admis­
sion (similarly reflected in 21% of the total), all 7 had a 
history of violence prior to this admission compared to 25 
(7 included) for the total group. 42.9% presented with alco­
hol abuse in the week prior to admission compared to 52.5% 
of the violent subset and 40% of the total. 42.9% tested 
positive for cannabis use compared to 42.5% of the violent 
subset and 30% of the total group. The only variable that 
was shared by all 7 subjects (100%) was the presence of 
delusions of control with the comparative figures 72.5% of 
the violent subset and 61% of the total group.
Discussion
Despite its relatively low prevalence, aggressive behav­
iour in a psychiatric setting has a major effect on morale 
amongst staff and patients when it occurs. Not only do 
patients with schizophrenia have to cope with the symp­
toms of their debilitating illness, they often also bear the 
consequences o f their violent behaviour even though these
behaviours tend to be mostly due 
to their illness and should thus 
generally lend themselves to pro­
ac tive  m anagem ent (B uckley , 
1999:52). Not surprisingly, reduced 
levels o f threatening behaviour, 
agitation and assault leads to a 
marked reduction in staff injury 
with a commensurate improvement 
in staff and patient morale and a 
dramatic improvement in the social 
e n v iro n m en t (M ally a  et al, 
1992:395). A clear need exists for 
the identification of those patients 
most at risk for violent behaviour 
in order to be able to effectively 
implement pro-active treatment re­
gimes as well as other appropriate 
preventative measures.
In our study, no difference could 
be demonstrated in the amount of 
antipsychotics, benzodiazepines 
or any combination administered when compared to the 
total NOSIE score. Therefore, the clinical judgement em­
ployed by the nursing staff to determine psychotropic use 
in the management of inpatient behaviour could not be 
captured by the NOSIE as no correlation between increased 
medication use and total scores could be shown. However, 
a possible linear relationship could be demonstrated be­
tween treatment dose and a score of 0-5 on a five item 
subset. Unfortunately, due to the small sample size, this 
could not be deliniated further.
Furtherm ore, no d ifference in the adm inistra tion  of 
psychotropics between the violent and non-violent sub­
sets could be demonstrated. Therefore, in this particular 
ward setting, the presence of a history of violent behaviour 
did not lead to any pro-active pharmacological manage­
ment, even though a number o f studies (Blomhoff et al, 
1990:771; Convit et al, 1988:429; Karson and Bigelow, 
1987; 161) have demonstrated that previous violent behav­
iour serves as a predictor of future violence.
Importantly however, the subgroup of seven violent sub­
jects (OAS positive) did receive statistically more intra­
muscular (as well as total) benzodiazepines compared to 
the rest of the study population. This further underlines 
the fact that in this particular setting violence was not pro­
actively managed but rather treated when it actually oc­
curred. As all 7 of these subjects had originally formed part 
of the violent subset, a pro-active management plan could 
in fact have prevented these incidents.
As mentioned in the background, the literature is not en­
tirely consistent with regards to the pharmacological man­
agement of violence. Some studies support the use of ei­
ther benzodiazepines or antipsychotics equally for the man­
agement of acute aggression (Dorevitch et al, 1999:142; 
Salzman, 1991:177). Other studies support the use of a com­
bination of antipsychotics and benzodiazepines. Current
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management protocols in the Western Cape for primary 
and secondary care facilities suggest the initial use of 
lorasepam, followed by haloperidol if an adequate response 
is not achieved within a 30 minute window.
Worldwide, the treatment of aggression in the acute inpa­
tient setting appears to show a move from a combination of 
benzodiazepines and typical antipsychotics, towards the 
co m b in a tio n  o f b e n zo d iazep in es  and a typ ica l 
antipsychotics. However, as the atypical antipsychotics 
are mostly unavailable in our psychiatric setting, they can­
not factor into current treatment practices.
The results of our study seem to indicate that current clini­
cal prescription practice at Stikland Hospital favours the 
use of intramuscular benzodiazepines for the management 
of acute aggression in the inpatient setting. This would be 
in keeping with the primary and secondary management 
protocol, with the exception that antipsychotics are sel­
dom added in the inpatient setting because the patient is 
either already receiving antipsychotics or the added ben­
efits of the ability to seclude a patient makes further admin­
istration of medication unnecessary.
The results would also seem to support the hypothesis 
that current clinical practice in this unit favours the ap­
proach of managing aggressive behaviour when it occurs 
rather than to pro-actively manage patients who are at 
higher risk for violent behaviour. Despite the inherent diffi­
culties in predicting violence, subjects admitted to this par­
ticular unit have previously been show to be at high risk if:
1. A history of previous violent behaviour was present and
2. Alcohol abuse took place in the week preceding admis­
sion (Koen et al, 2004:254). Therefore, specifically using 
criterium number one, the 7 violent incidents described 
could have been proactively managed as all were commit­
ted by subjects who had been documented on admission 
to have a history of violent behaviour. In this particular 
setting attention should possibly also be paid to the pres­
ence of delusions of control during the mental status ex­
amination on admission as this was the only other charac­
teristic that was shared by the group of seven. It should be 
kept in mind however that a proactive management proto­
col would have led to other subjects receiving more medi­
cation even though they did not eventually resort to a spe­
cific violent act on the ward. Therefore, in order to try and 
delineate even further which subjects are at risk for inpa­
tient violence, an evaluation tool that captures the nursing 
staff’s clinical judgement would be of^reat value to facili­
tate proactive management of only those subjects who are 
at highest risk for resorting to violent behaviourjiuring 
hospital admission.
Unfortunately the NOSIE, as used in this study, tailed to 
capture the clinical judgement employed by the nursing 
staff to determine psychotropic use in the management of 
inpatient behaviour as no correlation could be shown be­
tween increased medication use and total scores. The sub­
set of 5 questions however bears further scrutiny as some 
correlation could be identified with regards to the adminis­
tration of benzodiasepines. Further research in a larger
sample is needed to address the issue of whether this NOSIE 
subset score would be useful in determining where an in­
creased need for preventative measures and therefore 
timeous pharmacological intervention exists.
Limitations of this study mainly centred on inherent diffi­
culties with the definition of violence, the small number of 
subjects (especially those with high subset scores) and 
the reliance on previous history with possible recall bias.
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